Product Images Minocycline Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 9 images provide visual information about the product associated with Minocycline Hydrochloride NDC 65862-556 by Aurobindo Pharma Limited, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a medication package distributed in the US containing extended-release tablets of minocycline hydrochloride, manufactured by Aurobindo Pharma USA, Inc. The tablets have a 45mg dosage and the usual adult dosage is mentioned on the package. The tablets must be protected from light, moisture, and excessive heat. The package has printing in the overprinting zone coding area. Made in India.*
This is a description of a medication called Minocycline Hydrochloride Extended-Release Tablets, USP manufactured in India, with NDC number 65862-883-30. The medication is available only with a prescription and each extended-release tablet contains minocycline hydrochloride equivalent to minocycline 55 mg. The usual adult dosage can be found in the package insert. It is recommended to store the medication in tght, ight-resistant containers away from excess heat, light, and moisture. The medication should be kept out of reach of children. There is also information regarding the coding area and over printing zone.*
This is a description of a medication called Minocycline Hydrochloride. The extended-release tablets contain 65 mg of the active ingredient, minocycline. The medication is distributed by Aurohindo Pharma USA, Inc. and made in India. Adult dosages can be found in the package insert. The medication should be kept out of reach of children and stored in a tight, light-resistant container at a temperature of 20°C to 25°C. The packaging includes a coding area and dotted lines indicating printing zones.*
This is a description of a medication containing Minocycline hydrochloride, distributed in extended-release tablets by Aurobindo Pharma USA, Inc. The tablets are equivalent to minocycline 90 mg and the usual adult dosage can be found on the package. The medication should be kept out of reach of children and protected from light, moisture, and excessive heat. The package should be dispensed in tight and light-resistant containers as defined in the US conformities. The text also includes a product code and a lot number.*
The text is a description of medication containing Minocycline Hydrochloride in Extended-Release tablets. It is Rx only, distributed by Aurobindo Pharma USA, Inc. Each tablet contains minocycline hydrochloride, USP equivalent to minocycline 105 mg. The appropriate dosage for adults is included in the package insert. It must be kept out of reach of children and stored in tight, light-resistant containers at 20° to 25°C. The details to dispense are included within the coding area of the label.*
This is an extended-release drug called Minocycline Hydrochloride manufactured by Aurobindo Pharma USA Inc. It is only accessible via prescription and is available in 30 tablets. Each extended-release tablet contains 115 mg of minocycline hydrochloride, USP equivalent to minocycline. The drug is made in India and it is important to store it at 20° to 25°C (68° to 77°F) out of reach of children, and to protect it from light, moisture, and excessive heat. The usual adult dosage is recommended after consulting the package insert. The drug product is intended to be dispensed in tight, light-resistant containers as described in the USP. The code TS/DRUGS/22/2009 is available on the packaging.*
Minocycline Hydrochloride Extended-Release Tablets, USP by Aurobindo containing 30 tablets in each pack. Each extended-release tablet contains Minocycline Hydrochloride USP equivalent to minocycline 135 mg. It is a prescription medicine, dispensed in tight, light-resistant containers and needs to be kept out of reach of children. The usual adult dosage is mentioned in the package insert. It should be kept in a place between 20°C to 25°C (68°F to 77°F) to maintain the USP-controlled room temperature. It is made in India and distributed in the USA. The code number of the drug is TS/DRUGS/22/2009.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.